Impact of Margin-accentuation IRE in Pancreatic Cancer

Clinical trial NCT02952859 · TERMINATED

Trial details

NCT number: NCT02952859
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: TERMINATED
Study type: OBSERVATIONAL

Pancreatic Cancer

Start date: 2017-01-01
Primary completion: 2020-02-25
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.